Battling Acute Myeloid Leukemia (AML) as both a Clinician and Scientist

Authors

  • Reza Khorvash -
  • Ram Upadhyaya

Abstract

Acute myeloid leukemia (AML) is characterized by the accumulation of immature hematopoietic cells in the bone marrow that impair normal blood formation. Chemotherapy is always the first treatment option for AML. Patients can also be cured by allogeneic stem cell transplantation, which consists of transferring stem cells from a healthy donor to the patient after high-intensity (high-dose) chemotherapy. Many mutations found in AML affect the cells on an epigenetic level, influencing the gene expression of the cells such as influencing DNA-methylation genes and chromatin-modifying genes. Affecting these epigenetic mechanisms is therefore of great interest in the area of AML.

Downloads

Published

2020-03-31

How to Cite

Khorvash, R., & Upadhyaya, R. (2020). Battling Acute Myeloid Leukemia (AML) as both a Clinician and Scientist. Sciential - McMaster Undergraduate Science Journal, (4), 29-30. Retrieved from https://journals.mcmaster.ca/sciential/article/view/2425

Issue

Section

Interview